• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Funding roundup: Fresenius raises $1 billion through debt offering

Funding roundup: Fresenius raises $1 billion through debt offering

January 30, 2011 By MassDevice staff

Funding roundup

Here’s a roundup of the latest dealflow and investment news:

  • Fresenius raises $1 billion through debt offering
    Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis products and services, announced the pricing of US$-denominated and €-denominated senior unsecured notes in the principal amounts of $650 million and €300 million, respectively, both due 2021. The principal amount of the US$ senior notes was increased from the amount initially offered of $500 million. Net proceeds amounting to approximately US$1,033 million from the offering will be used to repay indebtedness, for acquisitions including the company’s recently announced acquisition of Euromedic’s dialysis service business and for general corporate purposes to support the renal products and services business.
    Read more
  • Nexstim Raises over €11 Million in New Equity Financing

    Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, announced that it has closed on additional equity financing of approximately EUR 11.4 million. The investment round was led by new investor Lundbeckfond Ventures (Denmark), with new investor Ilmarinen Mutual Pension Insurance Company (Finland) also joining Nexstim´s existing venture capital investors HealthCap and LSP (Life Sciences Partners), as well as Sitra and Finnish Industry Investment Ltd. To date, Nexstim has raised over EUR 30 million.
    Read more
  • OrthoSensor raises $21 million in Series B round
    OrthoSensor Inc., the leader in developing intelligent orthopedic implants and sensor-assisted surgery systems, announced that it has arranged $21 million in Series B financing. The Series B was led by Ziegler Meditech Equity Partners, LP, and an unnamed strategic investor. OrthoSensor is developing and commercializing intelligent orthopedic devices that will enable evidence-based orthopedic surgery and remote monitoring of orthopedic implants with the goal of improving patient outcomes and reducing the cost of treating musculoskeletal disease.
    Read more
  • Microvisk Technologies drums up $9.5 million
    Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £6 million through a rights issue to existing investors in an oversubscribed round. This is the third successful funding round for Microvisk, which has secured £10.5m in the past 12 months – the largest amount raised by a UK life science company.
    Read more
  • Digital Assent secures $2 Million series A financing to grow PatientPad point-of-care network
    Atlanta-based Digital Assent, provider of the PatientPad self-service patient check-in and patient education solution, announces the closing of a $2 million Series A round of equity financing led by Imlay Investments, Fulcrum Equity Partners and BLH Venture Partners.
    Read more
  • PhysioSonics Completes Series B Funding
    PhysioSonics Inc., an innovator of noninvasive neurologic monitors, announced the closure of its Series B financing in which Kirby Cramer, former Chairman of SonoSite (NSDQ:SONO), Co-led along with a strategic investor from Series A. The company will use the proceeds to commercialize its noninvasive neurology/cardiology monitor through the FDA approval process. PhysioSonics named Kirby Cramer as Chairman of the Board replacing founder Robert Frederickson Ph.D. who maintains his seat on the Board.
    Read more
  • XDx Announces New $12.5 Million Multi-draw Term Loan Facility with GE Capital, Healthcare Financial Services
    XDx Inc., a San Francisco-based molecular diagnostics company focused on non-invasive gene expression-based tests for the monitoring of organ transplant rejection and autoimmune diseases, announced that it has established a $12.5 million senior secured multi-draw term loan facility with GE Capital, Healthcare Financial Services. The financing provides the company with working capital to expand the commercialization of its FDA-cleared, innovative, non-invasive AlloMap molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases, including lupus.
    Read more

Filed Under: Business/Financial News, News Well

More recent news

  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out
  • Former Masimo COO is joining BD to run Connected Care

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy